{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:57:42Z","timestamp":1792587462519,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00464-022-09463-9","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T14:25:13Z","timestamp":1659536713000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["25 Years of the GERD-HRQL symptom severity instrument: an assessment of published applications"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-948X","authenticated-orcid":false,"given":"Vic","family":"Velanovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"9463_CR1","first-page":"217","volume":"183","author":"V Velanovich","year":"1996","unstructured":"Velanovich V, Vallance SR, Gusz JR et al (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217\u2013224","journal-title":"J Am Coll Surg"},{"key":"9463_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1442-2050.2007.00658.x","volume":"20","author":"V Velanovich","year":"2007","unstructured":"Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130\u2013134","journal-title":"Dis Esophagus"},{"key":"9463_CR3","unstructured":"Pubmed.ncbi.nlm.nih.gov, lasted Accessed January 2, 2022"},{"key":"9463_CR4","unstructured":"eprovide.mapi-trust.org, lasted Accessed January 2, 2022"},{"key":"9463_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MEG.0000000000001914","volume":"33","author":"A Balla","year":"2021","unstructured":"Balla A, Leone G, Ribichini E et al (2021) Gastroesophageal reflux disease-health related quality of life questionnaire: prospective development and validation in Italian. Eur J Gastroenterol Hepatol 33:339\u2013345","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9463_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/S0004-28032004000400012","volume":"41","author":"F Fornari","year":"2004","unstructured":"Fornari F, Crubes AC, Lopes AC et al (2004) Symptom\u2019s questionnaire for gastroesophageal reflux disease (Brazilian Portuguese). Arq Gastroenterol 41:263\u2013267","journal-title":"Arq Gastroenterol"},{"key":"9463_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1590\/S0004-28032007000200016","volume":"44","author":"GL Pereira","year":"2007","unstructured":"Pereira GL, Costa CD, Geocze L et al (2007) Cross-cultural adaptation and validation for Portuguese (Brasil) of the health related quality of life instrument specific for gastroesophageal reflux disease (Brazilian Portuguese). Arq Gastroenterol 44:168\u2013177","journal-title":"Arq Gastroenterol"},{"key":"9463_CR8","first-page":"59","volume":"92","author":"TJ Ionova","year":"2020","unstructured":"Ionova TJ, Nikitina TP, Mayevskaya EA et al (2020) Testing and validation of the Russian version of quality of life questionnaire in patients with GERD\u2014GERD-HRQL (Russian). Ter Arkh 92:59\u201366","journal-title":"Ter Arkh"},{"key":"9463_CR9","unstructured":"The 510(k) program: Evaluating substantial equivalence in premarket notifications [510(k)]. Guidance for industry and food and drug administration staff. Issued on July 28, 2014. www.fda.gov\/media\/82395\/download, lasted Accessed March 4, 2022"},{"key":"9463_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11605-016-3342-5","volume":"21","author":"B Fernandez","year":"2017","unstructured":"Fernandez B, Dore L, Velanovich V (2017) Patient-centered outcomes in surgical research and practice. J Gastrointest Surg 21:842\u2013895","journal-title":"J Gastrointest Surg"},{"key":"9463_CR11","first-page":"180","volume":"114","author":"LR Diniz","year":"2014","unstructured":"Diniz LR, Nesi J, Curi AC, Martins W (2014) Qualitative evaluation of osteopathic manipulation therapy in a patient with gastroesophageal reflux disease: a brief report. J Am Osteopath Assoc 114:180\u2013188","journal-title":"J Am Osteopath Assoc"},{"key":"9463_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5415813","author":"Z Luo","year":"2020","unstructured":"Luo Z, Hu X, Chen C et al (2020) Effect of catgut embedment in Du Meridian Acupoint on mental and psychological conditions of patients with gastroesophageal reflux disease. Evid Based Complem Alternat Med. https:\/\/doi.org\/10.1155\/2020\/5415813","journal-title":"Evid Based Complem Alternat Med"},{"issue":"64","key":"9463_CR13","first-page":"74.e3","volume":"90","author":"KS Dua","year":"2019","unstructured":"Dua KS, DeWitt JM, Kressler WR et al (2019) A phase III, multicenter, prospective, single-blinded, non-inferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video). Gastrointest Endosc 90(64):74.e3","journal-title":"Gastrointest Endosc"},{"key":"9463_CR14","first-page":"145561319","volume":"15","author":"JR Lechien","year":"2019","unstructured":"Lechien JR, Debie G, Mahillon V et al (2019) A 10 year follow-up of a randomized prospective study of 2 treatments for chronic rhinosinusitis without nasal polyps and investigation of the impact of gastroesophageal reflux disease in the resistance to treatment. Ear Nose Throat J 15:145561319","journal-title":"Ear Nose Throat J"},{"key":"9463_CR15","first-page":"59","volume":"11","author":"AM Altwigry","year":"2017","unstructured":"Altwigry AM, Almutairi MS, Ahmed M (2017) Gastroesophageal reflux disease prevalence among schoolteachers of Saudi Arabia and its impact on their daily activities. Int J Health Sci 11:59\u201364","journal-title":"Int J Health Sci"},{"key":"9463_CR16","first-page":"213","volume":"6","author":"H Rahimi","year":"2018","unstructured":"Rahimi H, Tavakol N (2018) Effects of Ramadan fasting on the symptoms of gastroesophageal reflux disease. J Nutr Fasting Health 6:213\u2013219","journal-title":"J Nutr Fasting Health"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09463-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-022-09463-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09463-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T20:08:07Z","timestamp":1673640487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-022-09463-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["9463"],"URL":"https:\/\/doi.org\/10.1007\/s00464-022-09463-9","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vic Velanovich receives speaker honoraria from Integra LifeSciences and consulting fees from Innocoll Biotherapeutics N.A., Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}